OPEN END TURBO BULL OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 09:11:18 27/06/2024 pm IST | ||
| 11.84 EUR | +0.85% |
|
| Current month | +8.30% | ||
| 1 month | +6.53% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 11.84 | +0.85% |
| 26/24/26 | 11.74 | -4.40% |
| 25/24/25 | 12.28 | +2.42% |
| 24/24/24 | 11.99 | +4.81% |
| 21/24/21 | 11.44 | +0.62% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 09:11 pm IST
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC73JB |
| ISIN | DE000HC73JB2 |
| Date issued | 31/05/2023 |
| Strike | 188.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.15 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.37 € |
|---|---|
| Lowest since issue | 3.65 € |
| Spread | 0.01 € |
| Spread % | 0.08% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.16%
- Stock Market
- Certificates
- Certificat
